As costs rise, employers drive change in health care delivery
A growing number of employers are taking an activist role in shaking up how care is delivered and paid for.
Since employers are continuing to ante up more dollars for their workers’ health plans, many are finding ways to tweak existing delivery models themselves, according to the Large Employers’ 2019 Health Care Strategy and Plan Design Survey by the National Business Group on Health.
The nonprofit surveyed 170 large employers and found that the total cost of providing medical and pharmacy benefits for employees and dependents will rise 5 percent, from an average $14,099 per employee this year to an average of $14,800 in 2019. Employers will cover roughly 70 percent of those costs, while employees will bear about 30 percent.
Related: Employers having second thoughts on HDHPs
High-cost claims, specialty pharmacy and specific diseases are the key drivers of cost increases, according to survey respondents.
“Health care cost increases continue to outpace workers’ earnings and increases in inflation, making this trend unaffordable and unsustainable over the long term,” says Brian Marcotte, president and CEO of the National Business Group on Health. “No longer able to rely on traditional cost sharing techniques to manage costs, a growing number of employers are taking an activist role in shaking up how care is delivered and paid for.”
Indeed, nearly half of respondents (49 percent) are either driving changes in the delivery system directly or through their health plan, leveraging digital solutions, or both. For example, 35 percent are implementing alternative payment and delivery models such as accountable care organizations and high performance networks either directly or through their health plan.
Moreover, direct contracting with health systems and providers is expanding, from 3 percent in 2018 to 11 percent in 2019. Direct contracting between employers and “centers of excellence” is also rising sharply, from 12 percent this year to 18 percent next year. Cancer, cardiovascular and fertility COEs are experiencing the greatest growth.
More than half of employers (52 percent) believe virtual care will play a significant role in how health care is delivered in the future while 43 percent believe artificial intelligence will play a major role. In fact, half of employers (51 percent) identified implementing more virtual care solutions as their top health care initiative in 2019. Virtual care has branched out well beyond physician consultations to include digital coaching, condition management, remote monitoring, physical therapy and cognitive behavioral therapy, all of which show the greatest potential for growth over the next several years.
“The growth in virtual solutions largely reflects employer frustration with the pace of change in how health care is delivered,” Marcotte says. “Interestingly, seven in ten employers believe new market entrants from outside the health care industry are needed to disrupt health care in a positive way. These disruptors include innovators from Silicon Valley and elsewhere, and employer coalitions.”
The survey also found nearly all employers believe the pharmaceutical supply chain needs to change — 14 percent say it needs to be more transparent, 35 percent say rebates need to be reduced, while half say the pharmaceutical supply chain is inefficient and too complex and needs to be overhauled and simplified. Additionally, three in four employers do not believe drug manufacturer rebates are an effective tool for helping to drive down pharmaceutical costs and over 90 percent would welcome an alternative to the rebate-driven approach to managing drug costs.
“Contracting within the pharmaceutical supply chain has not kept pace with today’s plan design reality,” Marcotte says. “The rebate-driven supply chain model is antiquated given the growth in high deductible plans and is ripe for change.”
According to the survey, more than half of the survey respondents are concerned that rebates do not benefit consumers at the point-of-sale. A growing number of companies (27 percent) are adopting recently developed capability by pharmacy benefit managers to pull rebates forward at the point of sale to benefit consumers. Another 31 percent are considering implementing point of sale rebates in the next few years.
Also, for the first time, employers are retrenching somewhat on account-based plans, though they are still widely offered. Employers offering full replacement consumer-directed health plans will shrink from 39 percent this year to 30 percent in 2019, the first time in four years fewer employers will offer these plans.
Among other findings from the survey:
– While 26 percent of employers are optimistic that mergers between health plans and PBMs will have a positive impact on cost, quality and consumer experience, the majority of employers are skeptical that they will see improvement from consolidation.
– A majority of employers (55 percent) are very concerned over the impact of prescription opioid abuse on the workforce. Employers are working with their partners to implement multiple strategies to change prescribing patterns and increasing access to alternative therapies.
– Three in ten large employers will conduct anti-stigma campaigns next year to reduce the stigma that exists around mental health conditions and treatment. More than half will offer self-directed online resources.